The development of Natural Killer (NK) cell therapeutics is a highly complex, multidisciplinary endeavor that necessitates a convergence of specialized expertise—from basic immunology and genetic engineering to advanced biomanufacturing and regulatory affairs. This complexity has led to a market structure heavily reliant on strategic collaborations. Partnerships between academic research...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek